.

Timothy G. Ventura

Chair, Philadelphia Professional Liability Practice Group

Portrait of Timothy G. Ventura

Tim is Chair of the Philadelphia Professional Liability Practice Group and the Insurance Agents and Brokers Liability Group. He focuses his practice on the defense of errors and omissions claims brought against insurance agents and brokers of all sizes. He also oversees and manages the day-to-day operations of a broad range of professional liability attorneys.  

While Tim’s practice is focused on defending insurance agents and brokers, he also frequently defends attorneys, corporate directors and officers, and a variety of real estate professionals, including title agents, appraisers, brokers, home inspectors and lenders in E&O and malpractice claims brought against them. He has successfully tried multiple cases as first chair counsel resulting in jury trial defense verdicts and tried dozens of arbitrations in Pennsylvania.  Tim also has experience defending product liability matters.

In addition to his civil litigation practice, Tim is a frequent speaker and author of publications on various topics regarding Insurance Agent/Broker Errors & Omissions, for clients, brokers, industry trade associations and professional liability insurers.

In 2003, Tim graduated from Boston College with a Bachelor of Arts in political science.  During the fall semester of his junior year at BC, he clerked for Senator John Kerry (D-MA).  Tim then attended Temple University Beasley School of Law in Philadelphia, PA, where he earned his juris doctor in 2006.  He achieved various honors while at Temple Law School, including: Temple University Law Faculty Scholarship recipient; Outstanding Oral Advocacy in Trial Advocacy; and Distinguished Classroom Performance – Civil Procedure.  He was also a staff member of the Temple Political and Civil Rights Law Review.

While attending Temple Law, Tim also worked part-time as a law clerk with Liberty Mutual Insurance Group in the Philadelphia Legal Department.

    • Temple University Beasley School of Law (J.D., 2006)
    • Boston College (B.A., 2003)
    • New Jersey, 2006
    • Pennsylvania, 2006
    • U.S. District Court Eastern District of Pennsylvania
    • American Bar Association
    • Claims and Litigation Management Alliance (CLM)
    • Pennsylvania Bar Association
    • Philadelphia Bar Association
    • Professional Liability Underwriting Society (PLUS)
    • The Seven-Ten Split Mock Trial: Navigating Agent Errors & Omissions, The Annual Professional Insurance Agents (PIA) Conference, Atlantic City, New Jersey, June 2, 2024
    • Pandemic Coverage Litigation Update / Insurance Broker Best Practices, Client Webinar, September 2022
    • The Aftermath of the Pandemic For Carriers and Agents, Client Webinar, July 2021
    • Pandemic Coverage Litigation Update - Agent E&O Wars to Come, Client Seminar, March 2021 
    • COVID 19 and Insurance Agent E&O, Best Practices, IA&B webinar, May 2020
    • Insurance Agent / Broker E&O Litigation Trends & Best Practices during COVID Crisis, Client Webinar, April 2020 
    • Insurance Agent / Broker E&O Litigation Trends & Best Practices, Client Seminar, April 2019
    • Insurance Agent / Broker E&O – Claims Prevention and Defense in 2018 and Beyond, Client webinar, February 2018
    • Mediation and Pre-Suit Claims Handling – Best Practices, Client Seminar, August 2016
    • Insurance Agent E&O Claims Prevention and Defense – The Road Ahead in 2016, Client Seminar, March 2016
    • Developments and Emerging Trends in the Legal and Insurance Areas of Cybersecurity, Client Seminar, February 2016
    • CPCU Society Webinar: Agent & Broker E&O - A New Lens for Viewing Exposures, September 18, 2015
    • Obtained a summary judgment dismissal in a Philadelphia Commerce Court commercial litigation matter. The case involved claims of unfair competition and tortious interference brought by one adult day care center against our client, a competing facility. The allegations centered on purported violations of regulations issued by the Pennsylvania Department of Aging and the Office of Long Term Living. The plaintiff’s final demand was $2 million, and no settlement offers were made before the trial court granted summary judgment.  
    • Obtained dismissal in Federal Court, Middle District of Pennsylvania, for insurance broker client in a case involving liability/commercial insurance coverage claims related to lost business income as a result of government mandated closures triggered by the COVID-19 pandemic.
    • Obtained summary judgment in Philadelphia County for our attorney/law firm client, dismissing a complex legal malpractice case involving claims of professional negligence and fraud that arose from an underlying personal injury litigation that concluded with a $700,000 settlement.  In the malpractice action, which involved various coverage and standard of care issues, Plaintiff sought approximately $2 million in damages.  Following discovery, the court granted our motion dismissing both the individual attorneys and firm clients with prejudice. For further details click here.
    • Obtained dismissal with prejudice of large automobile manufacturer client following motion oral argument. This case involved product liability claims regarding airbag deployment and alleged personal injuries caused by product defect.  No settlement offers made before suit was dismissed against client manufacturer. 
    • Defended insurance agency in Philadelphia Commerce Court action involving claims of professional negligence arising from the agency’s procurement of commercial insurance coverage for a hotel franchise owner.  Following a fire loss resulting in a completely rebuilt hotel property in Philadelphia, plaintiffs alleged their long-time insurance agency failed to obtain more comprehensive coverage available, including insufficient business interruption and ordinance or law coverage.  Plaintiffs also asserted breach of contract/bad faith claims against the insurer co-defendant.  With case exposure exceeding $8.5 million, following discovery and before trial, settled suit at mediation on behalf of insurance agency client with payment in the range of defense costs, a fraction of the total exposure and settlement demand.
    • Obtained jury trial defense verdict on behalf of large automobile manufacturer/distributor in Philadelphia County, Pennsylvania following four-day trial involving multiple party, fact witness and experts’ testimony.
    • Obtained jury trial defense verdict on behalf of product manufacturer in Lehigh County, Pennsylvania following three-day trial involving party, witness and multiple experts' testimony.
    • Obtained non-suit judgment for insurance broker at arbitration in Delaware County, Pennsylvania.
    • Obtained defense verdict for large automobile manufacturer at arbitration in Philadelphia County in a product liability suit involving fire cause and origin issues, with live expert testimony for both parties.
    • Obtained Non-Pros judgment in favor of wholesale insurance broker client in Philadelphia County, Pennsylvania.  After serving plaintiff's counsel with letters threatening sanctions and fees under Pa.R.C.P. 1023.1, and the prospect of a retaliatory suit against plaintiff's counsel for wrongful use of civil proceedings, because plaintiff's claims against the wholesale insurance broker lacked probable cause, plaintiff's counsel promptly withdrew representation and the suit languished resulting in a Non Pros judgment with no indemnity paid.
    • Obtained favorable outcome for large construction company client at private binding arbitration in a personal injury suit with a settlement demand of $600,000.  Following successful defense at arbitration, with multiple party and witness testimony and experts, the award resulted in client paying less than cost of trial defense.
    • Assisted first chair counsel in successful jury trial in Philadelphia County Court of Common Pleas.  Breach of contract/indemnity action representing construction manager against a sub-contractor, resulting in jury verdict recovery in excess of $750,000 on behalf of client.  Drafted successful pre-trial and post-trial motions, fact and expert witness coordination, with trial conference participation.
    • Obtained voluntary suit dismissal of plaintiff in legal malpractice suit with $2 million initial settlement demand after drafting successful Motion for Summary Judgment and procuring multiple defense expert reports on behalf of law firm and individual attorney clients.  Dispositive Motion established plaintiff's failure to prove her underlying case within the case and causation in professional negligence action, including the use of digital metadata analysis and litigation attorney expert opinion.
    • Defending for over ten years the manufacturer, designer and distributor of automobiles, motorcycles and varied power equipment in catastrophic injury, product liability and warranty actions.
    • Defending for over 8 years multiple wholesale and retail auto finance companies in commercial litigation and lender liability suits involving claims of fraud, breach of contract, professional negligence and unfair trade practices.

Results

Philadelphia Commerce Court Grants Summary Judgment, Dismissing $2M Unfair‑Competition and Tortious‑Interference Claims

We obtained summary judgment dismissal, following Oral Argument, in a Philadelphia Commerce Court commercial litigation matter involving allegations of unfair competition and tortious inference with contract and business relationships, brought by one adult day care center against our client, a competing adult day care facility.  The plaintiff’s suit stemmed from alleged violation of regulations set forth by the Pennsylvania Department of Aging and its Office of Long-Term Living. The plaintiff’s final demand was $2 million, and no settlement offers were made before the trial court granted summary judgment.

Montgomery County Court Dismisses Lawsuit Against Insurance Broker

We obtained dismissal of our insurance broker client on Motion for Summary Judgment in the Montgomery County Court of Common Pleas, Pennsylvania, on the basis of no duty breached, and lack of causation. Claimants asserted a professional negligence theory for allegedly allowing a commercial insurance policy to lapse, failing to notify the policyholder claimant of the lapse or cancellation, and allowing a subsequent gap in coverage to exist after the policy cancelled, when an underlying loss occurred. However, after completed discovery depositions and expert discovery, we successfully moved for summary judgment, arguing the policy cancelled because of the policyholder’s own failure to comply with premium audit requirements, rather than any liability or breach of standard of care by the insurance broker.

Thought Leadership

Defense Digest

On the Pulse…Defending the Professionals Who Power the Insurance Industry

March 1, 2026

The Insurance Agents and Brokers Defense Practice Group at Marshall Dennehey is nationally recognized for its skillful representation of insurance professionals in complex civil litigation. With decades of collective experience, our attorneys provide sophisticated, results-driven defense to insurance agents, brokers, managing general agents, and other intermediaries facing professional liability claims. We understand the intricate regulatory frameworks, contractual obligations, and industry standards that govern the insurance marketplace, allowing us to craft defenses that reflect both legal prowess and practical business insight. Our team regularly defends clients in claims alleging negligence, misrepresentation, breach of fiduciary duty, failure to procure coverage, and errors in policy placement or renewal. We also handle disputes arising from alleged bad faith, premium miscalculations, claims denial, and compliance violations. Whether the matter involves a single claim or a multi-jurisdictional class action, our attorneys have the depth of knowledge and trial experience necessary to protect our clients’ reputations and minimize their exposure. Beyond litigation, our practice group emphasizes proactive risk management and claim prevention. We partner with insurance agencies and brokerages to conduct internal audits, develop best practices, and deliver training on evolving industry risks, emerging coverage issues, and regulatory developments. This preventative approach reflects our broader commitment to supporting our clients as trusted advisors, not just defenders, throughout the life of their businesses. At Marshall Dennehey we understand that every claim against an insurance professional carries significant professional and reputational consequences. Our clients rely on us for strategic, efficient, and discreet representation that aligns with their long-term business goals. By combining deep industry knowledge with vigorous advocacy and an unwavering commitment to service, our Insurance Agents and Brokers Defense Practice Group stands at the forefront of protecting the professionals who keep the insurance industry moving. Tim is Chair of the Professional Liability Practice Group, and he can be reached at TGVentura@MDWCG.com.

PLUS Blog

Pennsylvania Superior Court Rejects Breach of Oral Contract Claim Against Insurance Agent

January 26, 2026

While the majority of claims against insurance agents and brokers sound in tort, creative attorneys attempting to combat a two-year statute of limitations on tort claims or the affirmative defense of contributory negligence, may also plead a breach of oral contract claim. In Pennsylvania, contract claims have a four-year statute of limitations and are not barred by the doctrine of contributory negligence. Insureds’ counsel therefore have an incentive to try to plead tort and contract claims, both procedurally and substantively.

Firm Highlights

Thought Leadership

SIDEBAR: News and Happenings

We are pleased to share that attorneys from our health care team have been selected to the 2026  New Jersey and Pennsylvania Super Lawyers and Rising Stars lists. Their dedication to clients and commitment to high-quality work continues to strengthen our firm! Please join us in congratulating: NJ Super Lawyers: Robert T. Evers and Justin F. Johnson NJ Super Lawyer Rising Stars: Nataliana A. Guida  2026 Pennsylvania Super Lawyers: Alyson J. Kirleis and Gary M. Samms 2026 Pennsylvania Rising Stars: Holli K. Archer and Daniel Dolente Victoria Scanlon (Scranton) was a faculty presenter at the 2026 American Roentgen Ray Society (ARRS) Annual Meeting in Pittsburgh. She participated in the “Resident Symposium: Producing Quality Reports,” focusing her presentation on “How to Write a Great Report: Malpractice Lawyer’s Perspective.” Vicky, the only attorney presenter for this two-hour segment, was joined by several health care professionals including diagnostic radiologists, an interventional radiologist, an internal medicine physician, and a radiologist turned AI entrepreneur expert.  Matthew Keris (Scranton), President of the Pennsylvania Association for Health Care Risk Management (PAHCRM) and shareholder in our Scranton Health Care Department, presented an important and timely session titled “Keynote Address: A Conversation with RaDonda Vaught on Criminalizing Errors” at PAHCRM’s Annual Meeting in April. RaDonda is a former Tennessee nurse widely known for being criminally convicted in 2022 of negligent homicide and gross neglect after a 2017 fatal medication error at Vanderbilt University Medical Center. Her case gained national attention because she was criminally prosecuted rather than just facing licensing board action, sparking debate over blaming individual nurses for systemic healthcare failures. Matt and RaDonda’s conversation explored one of the most consequential issues in health care risk management today—how systems respond to human error, and what it means for patient safety, accountability, and the professionals who serve on the front lines. Gary Samms was a panelist for a podcast hosted by the Medical Liability Monitor, “From Outliers to Pattern: The Increasing Predictability of Megaverdicts in the Med-Mal Industry – and How to Reduce the Likelihood of Getting Hit with One.” Gary discussed the changing megaverdict landscape and why “outlier” verdicts are becoming structural, in addition to how plaintiffs turn weaknesses into megaverdicts (including building emotional narrative and jury psychology). Thank you to our clients who joined us for our Trends in Health Care & Health Law seminar on May 14. Led by our Health Care Department Director and Assistant Director, Robin Snyder and Donna Modestine, the session explored key issues that are currently shaping outcomes in health care litigation. We owe a debt of gratitude to our esteemed guest speaker, Mary Ellen Nepps, Esq., Senior Counsel, University of Pennsylvania, who presented “Medical Malpractice Litigation: Driving Another Health Care Crisis in Pennsylvania.” And special thanks to our attorneys who presented and shared their insights, including John J. Hare and Holli Archer who discussed “Highlights in PA Medical Malpractice Law;” David Drake for his presentation, “From Claims to Courtroom: Key Trends in NJ Medical Malpractice Litigation;” and Matthew Keris with an “Update on Health Care Tech Discovery.” Thank you to all of our clients for entrusting us with your health care litigation. We are proud to partner with you as we defend your interests and navigate legal landscapes together.

Result

No-Cause Jury Verdict Secured in Wrongful Death Trial

We successfully obtained a no-cause jury verdict in a 13-day wrongful death trial. The decedent, a 59-year-old man, was admitted to the emergency room on February 15, 2019, with complaints of abdominal pain, decreased appetite, and constipation, despite the use of laxatives. The patient did not complain of any nausea, vomiting, or diarrhea. He had a significant medical history including diabetes, hypertension, prior coronary artery stenting, morbid obesity (with past gastric bypass surgery), longstanding ventral hernia, and back pain. A CT scan revealed multiple hernias and a potential closed-loop bowel obstruction, leading to a surgery consultation. Our client, an emergency general surgeon, interpreted that the patient did not have a closed loop or any significant obstruction and recommended non-surgical management. The patient was approved to have clear liquids, and had a vomiting incident shortly after, but our client was not notified. The patient was returned to NPO status, and after improving overnight, he was returned to “clears” and additional medical and renal consults were ordered. Our client did not receive any communications from the residents/nurses of any changes in the patient’s condition. On February 18, 2019, two rapid responses were called due to increased heart rate and vomiting. It is believed that the vomiting resulted in aspiration, causing sepsis, ultimately leading to the patient’s death. During the trial, the plaintiff’s sole medical expert highlighted imaging on the wrong hernia, which called into question all of his opinions in the case. We made key objections related to the expert testimony, limiting what the allegations were, and preventing new allegations from being made. After approximately two and a half hours of deliberating, the jury returned a no-cause verdict. 

News

Marshall Dennehey’s John J. Hare Brings Home Attorney of the Year Honors; Firm Named Litigation Department of the Year in Two Categories

Marshall Dennehey took home top honors in three categories at the The Legal Intelligencer’s 2026 Pennsylvania Legal Awards, held June 11 in Philadelphia. The first place awards include: Attorney of the Year: John J. Hare, Chair of the firm’s Appellate Advocacy & Post-Trial Practice Group and Executive Committee member, together with Charles “Chip” Becker of Kline & Specter Litigation Department of the Year, Appellate – Third Win in a Row! Litigation Department of the Year, Product Liability/Mass Torts “There is no one more deserving of Attorney of the Year honors than John. This award is a testament to his exceptional skill, dedication, and leadership—qualities that truly exemplify the very best of our firm,” said G. Mark Thompson, Marshall Dennehey’s President & CEO. “These honors also reflect the strength and depth of our product liability, mass torts, and appellate practices across Pennsylvania and beyond, underscoring our ongoing commitment to delivering outstanding results for our clients.” Attorney of the Year – John J. Hare, Marshall Dennehey, together with Charles “Chip” Becker, Kline & Specter Over the past year, John and Charles were opposing counsel in many of the highest-profile civil appeals in Pennsylvania. John is renowned as a preeminent appellate lawyer on the defense side, and Chip on the plaintiff's side. They have opposed each other repeatedly, exhibiting peerless professionalism and exceptional civility, while zealously litigating under the unremitting pressure of high-profile litigation and record-setting verdicts totaling more than $3.5 billion. They have also collaborated, outside of litigation, on many commissions, committees, and projects of importance to the Pennsylvania judiciary and legal community. Litigation Department of the Year – Appellate Law, Winner (previous winner, 2025 and 2024) 2025 was another standout year for the firm’s Appellate Advocacy & Post‑Trial Practice Group, led by John J. Hare, which was retained to challenge many of Pennsylvania’s “nuclear” verdicts—awards exceeding $10 million. Notably, the department persuaded the Pennsylvania Superior Court to reverse a Philadelphia judgment of $1.09 billion, the largest judgment ever overturned by a Pennsylvania appellate court. The group’s 11 full‑time Pennsylvania‑based appellate lawyers are at the center of Pennsylvania’s most high-profile matters, bringing more than 150 years of combined appellate experience. They routinely handle post‑trial and appellate matters and are frequently engaged to participate in and monitor trials in high‑exposure cases to ensure that critical legal issues are properly raised and preserved for appeal. Litigation Department of the Year – Product Liability/Mass Torts, Winner This marks the first win for the firm’s Pennsylvania Product Liability and Mass Torts practices, which operate within our Casualty Department, managed by Matthew Schorr and Jeff Rapattoni. For almost five decades, Fortune 500 product manufacturers/distributors and their insurers have turned to these groups to defend their litigation. Led by Bradley D. Remick and Vlada Tasich, our Product Liability group’s success can be attributed to its commitment to keeping abreast of ever-changing legal theories, judicial viewpoints, and evolving technology impacting the product liability landscape. Our attorneys have successfully handled thousands of product liability matters in all jurisdictions across the state. Likewise, our mass tort litigation practice – divided into Asbestos & Mass Tort, and Environmental & Toxic Tort Litigation –  has defended manufacturers, distributors, contractors, and premises owners in thousands of personal injury and other claims. Led by Kevin E. Hexstall and Patrick T. Reilly, most attorneys in these groups have more than 20 years of experience, and our seasoned trial team has tried hundreds of cases to verdict, consistently achieving strong results through both trials and settlements. In addition to these awards, Marshall Dennehey was a Litigation Department of the Year finalist for Professional Liability.

Thought Leadership

Casual Care, Serious Consequences: How Informal Prescribing Can Trigger Medical Board Scrutiny

The lesson for health care practitioners is that regular review of the regulatory requirements can ensure compliance and that casual prescribing may be in violation of state regulations if the necessary components are not met. Consider the following scenario: in December 2025, a medical provider renewed a prescription for a long-standing telemedicine patient receiving a Schedule II controlled dangerous substance. This was not a violation of the New Jersey Administrative Code. Another provider doing the same action for an equally situated patient in March 2026 would be in violation. The casual prescriber who is not aware of newer regulatory requirements may have a more difficult time responding to a medical board complaint. Medicine is a highly-regulated helping profession. Without addressing the merits of this regulatory burden, the practice of medicine continues to see drastic changes impacting the everyday life of patient and provider. Telemedicine, COVID-19, and other advances and roadblocks, present a challenge to those saving lives while attempting to comply with the rules of practice. Physicians often discover—through real cases and the lens of regulatory expectations—that even well-intentioned informal help can be reinterpreted as stepping outside mandated professional boundaries, and seemingly harmless actions can be construed as deviations from required practice standards specifically outlined in Title 13, Chapter 35, Subchapters 7.1A of the New Jersey Administrative Code. Title 45, "Professions and Occupations," of the New Jersey code governs the practice of medicine, nursing, optometry, pharmacy, and many other professional occupations. Section 9 specifically addresses the state board of medical examiners and allows for the creation of rules and regulations in Section 45:9-5.3. These regulations can be found in the New Jersey Administrative Code Title 13, Chapter 35. While broad in scope, Chapter 35 contains a subchapter dedicated to the administration and dispensing of prescription drugs. Such knowledge will arm physicians with the tools they need to prevent a negative outcome if a medical board complaint is filed. Likewise, attorneys must be familiar with these regulatory requirements when advising and defending providers. In New Jersey, N.J.A.C. Section 13:35-7.1A(a) requires that a practitioner conduct an examination and appropriately document the same within the medical record before dispensing drugs or issuing prescriptions. The examination must include an "appropriate history and physical examination," a diagnosis based upon the examination and any testing consistent with good medical care, the formulation of a therapeutic plan discussed with the patient, and the availability of appropriate follow-up care. There are only six exceptions to this requirement: In admission orders for a newly hospitalized patient For a patient of another physician for whom the practitioner is taking calls For continuation medications on a short-term basis for a new patient prior to the patient's first appointment For an established patient who, based on sound medical practice, the physician believes does not require a new examination before issuing a new prescription For a patient examined by a healthcare professional who is in collaborative practice with the practitioner When treatment is provided by a practitioner for an emergency medical condition Emergencies are also limited to situations where someone's health is in serious jeopardy, there is serious impairment to bodily functions, or serious dysfunction of any bodily organ or part. During the COVID-19 pandemic, then New Jersey Governor Phil Murphy issued an executive order declaring a public health emergency and a state of emergency that allowed authorized prescribers to prescribe Schedule II controlled dangerous substances via telemedicine. The order was terminated when he left office earlier this year and the state reverted to the requirement of an initial in-person examination and quarterly in-person visits. With this return to prior regulatory requirements, practitioners subject to the jurisdiction of the board of medical examiners may benefit from a refresher on the regulatory limitations on their practice now that the pandemic-era flexibilities have ended. This new requirement may create confusion for prescribers and lead to casual prescribing of medication in violation of the regulations, even in the setting of recurrent telemedicine appointments as noted in the example above. Casual prescribing can take many forms: filling a prescription request from a friend or family member without an examination or contemporary medical record; using telemedicine to expand your practice without proper in-person appointments or documentation in the medical record; failing to ensure appropriate follow-up care for a "one time" prescription; etc. Although not all board complaints end in a publicly available opinion, serious deviations from regulatory requirements can shine a light on practices that will require action by the board if a complaint is received. Consider the following cases: In October 2025, the board issued a final consent order in an administrative action where a doctor provided opioids without examination and his license was permanently revoked. In re Robert Dela Gente, D.O., N.J. State Bd. of Med. Exam'rs Oct. 21, 2025. Criminal charges were filed (though that is not always the case). In a September 2025 consent order, a physician was reprimanded for "prescribing opioids several months in advance without the proper patient follow-up..." and explained that they did so for "patients who can not pay for multiple visits to refill medications." In re A/an E. Schultz, M.D., N.J. State Bd. of Med. Exam'rs Sept. 25, 2025. Another physician was suspended and placed on probation in a consent order for prescribing three patients the weight-loss medication "Ozempic" via text messages through a website called "Push Health" and without any further communication with the patients or taking a medical history. In re Laura E. Purdy, M.D., N.J. State Bd. of Med. Exam'rs Aug. 29, 2025. A June 2025 interim consent order required a "full evaluation and assessment of [a physician's] general knowledge and skill, with specific emphasis on his knowledge of and ability to safely prescribe [controlled dangerous substances]" due to his failure to review a patient's prior medical history and medical record, assess and review the prescription monitoring program before prescribing CDS, and conduct random urine screens on a patient that tested positive for CDS upon admission to his practice because "he trusted the patient." In re Donald Oh, M.D., N.J. State Bd. of Med. Exam'rs June 2, 2025. Each of these examples demonstrate a failure to follow strict procedure regardless of the intention. Failing to follow procedure secondary to good intentions, such as considering a patient's financial constraints, trust in the patient, or utilizing a new telemedicine service platform, will not be a defense to a board complaint. Especially when practicing via telemedicine, practitioners must ensure they are adhering to the appropriate regulatory standard. A provider who calls in a prescription for a traveling friend or family member or agrees to prescribe medication for individuals using the newest phone app will have a hard time meeting the requirements of N.J.A.C. Section 13:35-7.1A. Even if a history was taken, a "therapeutic plan" was created, and "follow up care" was provided, the prescriber would still not be in compliance with the regulation without an in-person examination. In our opening hypothetical, the prescriber's behavior did not change between December and March; however, the legal shift in the regulatory landscape made once acceptable behavior a violation as a required examination did not occur. When complaints are made with regard to informal prescribing, the board has discretion to employ measures to encourage compliance in lieu of formal proceedings such as a private, written warning; suspending fines subject to continuing compliance; medical or professional treatment as may be necessary; medical or diagnostic testing and monitoring; skills assessment; corrective training; participation in outreach programming; or contribution to the consumer fraud protection fund. The lesson for health care practitioners is that regular review of the regulatory requirements can ensure compliance and that casual prescribing may be in violation of state regulations if the necessary components are not met. Even compliant providers who had not conducted an in-person examination for telemedicine patients during the COVID-19 emergency would be in violation of the regulations as of January 2026 for the same practice. Practitioners should be diligent in adhering to the prescribing rules to avoid sanctions related to casual care. Likewise, attorneys advising or defending practitioners before the board must be aware of the in-person examination requirements for prescribing in New Jersey whether the care in question took place in-person or in a telemedicine setting. Reprinted with permission from the April 22, 2026 issue of the New Jersey Law Journal. ©2026 ALM Media Properties, LLC. Further duplication without permission is prohibited. All rights reserved.